| abstract |
The present invention provides methods relating to novel therapeutic strategies for treating cancer and inflammatory diseases. In particular, the method comprises administering a pharmaceutical composition comprising a compound of formula I, or a pharmaceutically acceptable salt thereof, or such compound mixed with at least one pharmaceutically acceptable additive. including. The cancer is a hematological malignancy, and the hematologic malignancy includes acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), multiple myeloma (MM), And non-Hodgkin's lymphoma (NHL). |